MYD88 Inhibitor ST2825 Suppresses the Growth of Lymphoma and Leukaemia Cells.
Sign Up to like & getrecommendations! Published in 2017 at "Anticancer research"
DOI: 10.21873/anticanres.12070
Abstract: BACKGROUND/AIM Myeloid differentiation primary response gene 88 (MYD88), which activates the nuclear factor kappa B (NF-κB) pathway, is important for the growth of lymphoma and leukaemia cells. In this study, we investigated the effects of… read more here.
Keywords: lymphoma leukaemia; leukaemia cells; st2825; growth lymphoma ... See more keywords